Q2 EPS Estimates for Core Laboratories Cut by Zacks Research

Core Laboratories Inc. (NYSE:CLB) – Analysts at Zacks Research dropped their Q2 2025 EPS estimates for Core Laboratories in a report issued on Wednesday, May 14th. Zacks Research analyst R. Department now forecasts that the oil and gas company will post earnings per share of $0.18 for the quarter, down from their prior estimate of $0.21. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q3 2025 earnings at $0.20 EPS, Q4 2025 earnings at $0.21 EPS, FY2025 earnings at $0.73 EPS, Q2 2026 earnings at $0.20 EPS, Q3 2026 earnings at $0.25 EPS, FY2026 earnings at $0.91 EPS and Q1 2027 earnings at $0.24 EPS.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The business had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. During the same quarter in the prior year, the business posted $0.19 earnings per share. Core Laboratories’s revenue for the quarter was down 4.7% on a year-over-year basis.

CLB has been the topic of several other reports. Stifel Nicolaus decreased their target price on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a report on Tuesday, April 15th. StockNews.com lowered shares of Core Laboratories from a “hold” rating to a “sell” rating in a report on Friday, April 25th. Finally, Citigroup decreased their target price on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, May 13th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $15.00.

Core Laboratories Price Performance

Shares of CLB opened at $11.89 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.32 and a debt-to-equity ratio of 0.49. The company has a market cap of $557.35 million, a price-to-earnings ratio of 18.01, a price-to-earnings-growth ratio of 0.99 and a beta of 1.45. The company has a 50 day moving average of $13.01 and a two-hundred day moving average of $16.46. Core Laboratories has a twelve month low of $10.14 and a twelve month high of $25.13.

Institutional Investors Weigh In On Core Laboratories

A number of institutional investors and hedge funds have recently made changes to their positions in CLB. Ariel Investments LLC raised its stake in shares of Core Laboratories by 7.4% in the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company’s stock valued at $155,027,000 after acquiring an additional 709,455 shares during the period. Hotchkis & Wiley Capital Management LLC purchased a new stake in Core Laboratories during the 1st quarter worth approximately $6,008,000. Raymond James Financial Inc. purchased a new stake in Core Laboratories during the 4th quarter worth approximately $6,760,000. Fred Alger Management LLC increased its stake in Core Laboratories by 32.4% during the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock worth $11,045,000 after buying an additional 180,344 shares during the period. Finally, Nuveen LLC purchased a new stake in Core Laboratories during the 1st quarter worth approximately $2,573,000. 97.81% of the stock is owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories’s dividend payout ratio (DPR) is 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.